[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Aceinavir (1 gram uncoated tablet): Arm A would enroll 22 moderately symptomatic COVID-19 subjects treated with Aceinavir (Investigational Product) and Standard of Care (SoC). Dose is 4 tablets thrice daily till end of clinical recovery or as per the discretion of clinical investigatorControl Intervention1: Standard of Care (SoC): Arm B would enroll 22 moderately symptomatic COVID-19 subjects treated with SoC.The Standard of Care(SoC) will be as per the local hospital protocol and as per recommendations / guidelines by the respective authorities (Ministry of Health and Family Welfare; CDC and USFDA) whichever fits best at the time of initiation of this study. This will also be followed by the best supportive care guidelines recommended by the authorities (Ministry of Health and Family Welfare; CDC and USFDA).", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Aceinavir (1 gram uncoated tablet): Arm A would enroll 22 moderately symptomatic COVID-19 subjects treated with Aceinavir (Investigational Product) and Standard of Care (SoC). Dose is 4 tablets thrice daily till end of clinical recovery or as per the discretion of clinical investigator", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Standard of Care (SoC): Arm B would enroll 22 moderately symptomatic COVID-19 subjects treated with SoC.The Standard of Care(SoC) will be as per the local hospital protocol and as per recommendations / guidelines by the respective authorities (Ministry of Health and Family Welfare; CDC and USFDA) whichever fits best at the time of initiation of this study. This will also be followed by the best supportive care guidelines recommended by the authorities (Ministry of Health and Family Welfare; CDC and USFDA).", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 16, "treatment_name": "Aceinavir", "treatment_type": "Others pharmacological treatment", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Aceinavir (1 gram uncoated tablet): Arm A would enroll 22 moderately symptomatic COVID-19 subjects treated with Aceinavir (Investigational Product) and Standard of Care (SoC). Dose is 4 tablets thrice daily till end of clinical recovery or as per the discretion of clinical investigatorControl Intervention1: Standard of Care (SoC): Arm B would enroll 22 moderately symptomatic COVID-19 subjects treated with SoC.The Standard of Care(SoC) will be as per the local hospital protocol and as per recommendations / guidelines by the respective authorities (Ministry of Health and Family Welfare; CDC and USFDA) whichever fits best at the time of initiation of this study. This will also be followed by the best supportive care guidelines recommended by the authorities (Ministry of Health and Family Welfare; CDC and USFDA).", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Aceinavir (1 gram uncoated tablet): Arm A would enroll 22 moderately symptomatic COVID-19 subjects treated with Aceinavir (Investigational Product) and Standard of Care (SoC). Dose is 4 tablets thrice daily till end of clinical recovery or as per the discretion of clinical investigator", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Standard of Care (SoC): Arm B would enroll 22 moderately symptomatic COVID-19 subjects treated with SoC.The Standard of Care(SoC) will be as per the local hospital protocol and as per recommendations / guidelines by the respective authorities (Ministry of Health and Family Welfare; CDC and USFDA) whichever fits best at the time of initiation of this study. This will also be followed by the best supportive care guidelines recommended by the authorities (Ministry of Health and Family Welfare; CDC and USFDA).", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]